Current Value of Holding

$569 Million

Shares

2.1 Million

% of Portfolio

33.29%

Average Buy Price

$225

Avg closing price
Price range

7 John Paulson Madrigal Pharmaceuticals Trades

John Paulson acquired 2.1 Million Madrigal Pharmaceuticals shares worth $569 Million. It makes up 33.29% of their stock portfolio and is their biggest holding. The investor owns 9.57% of the outstanding Madrigal Pharmaceuticals stock. The stake costed the investor $473 Million, netting the investor a gain of 20% so far.

Avg closing price
Price range
Increased shares by 2.8% (+57.5 Thousand shares) Q1 2025
Avg closing price $328.25
Price range $272.79 - $355.88
Increased shares by 10.4% (+192 Thousand shares) Q3 2024
Avg closing price $255.94
Price range $212.22 - $292.96
Increased shares by 4.2% (+75 Thousand shares) Q2 2024
Avg closing price $238.04
Price range $193.33 - $291.99
Increased shares by 60.5% (+669 Thousand shares) Q1 2024
Avg closing price $235.62
Price range $171.37 - $283.23
Increased shares by 121.1% (+606 Thousand shares) Q4 2023
Avg closing price $174.99
Price range $120.40 - $237.13
Increased shares by 42.8% (+150 Thousand shares) Q3 2023
Avg closing price $188.22
Price range $146.04 - $225.78
New holding (+350 Thousand shares) Q2 2023
Avg closing price $270.85
Price range $203.88 - $312.00

News about Madrigal Pharmaceuticals Inc and John Paulson

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!